Mazdutide Survodutide cagrilintide 2.5mg+Samaglutide2.5mg MZ SUR10 CS5 Ensure safe delivery
TDS 26 Inquiries
67727-97-3
Pharmaceutical Grade
99%
shenzhen
sc
5mg / 10mg . 10 bottles per box
2027-11-30
tr
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionLys-Pro-Val is an oligopeptide.Certificates
-
TDS
Basic Info-
Product Name:
ALPHA-MSH (11-13) ACETATE SALT
Other Name:H-LYS-PRO-VAL-OH ACETATE SALT;H-LYS-PRO-VAL-OH ACOH;ALPHA-MSH (11-13);ALPHA-MSH (11-13) ACETATE SALT;msh(11-13;.alpha.-MSH (11-13) (free acid);H-Lys-Pro-Val-OH;alpha-Msh (11-13) (free acid) acetate salt
CAS No.:67727-97-3
Molecular Formula:C18H34N4O6
InChIKeys:YSPZCHGIWAQVKQ-AVGNSLFASA-N
Molecular Weight:402.49
Exact Mass:342.226705
Categories:
Characteristics-
PSA:
139
Storage Conditions:-15°C
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
tr
-
Location:
B27 SHING LEE COMM BLDG 8WING KUT ST CENTRAL HONGKONG
-
Average lead Time:
1
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Inquiry History26 Inquiries
Country Product Purchase Quantity Date Posted
Brazil
67727-97-3
10 MT Apr 30, 2026
United States
Klow blends 80mg 10 vials
10 MG Feb 12, 2026
United States
KPV
0.1 G Jul 13, 2026
Canada
Kpv
10 G May 9, 2026
United States
kpv
1 KG May 8, 2026
Canada
KPV | US Warehouse | Cosmetic Peptides | 99% Purity | 5mg 10mg Vials | Lyophilized Powder
10 MG Apr 16, 2026
United States
KLOW
1 MT Apr 15, 2026
Brazil
kpv
10 MT Mar 12, 2026
United States
KPV
10 MG Feb 28, 2026
United States
Klow80
10 MT Jul 29, 2026
United States
Klow80
1 MT May 23, 2026
Canada
KPV
1 KG Nov 24, 2025
United States
KPV
50 MG Nov 10, 2025
United States
KlOW
20 Aug 9, 2026
Netherlands
klow
10 MT Jul 9, 2026
United States
Klow
800 MG Jul 3, 2026
United States
KPV
2 KG Jun 19, 2026
Portugal
KLOW
80 MG May 28, 2026
United States
KPV (KLOW)
100 MT May 18, 2026
United States
Glow blend
10 MT Apr 4, 2026 Post an enquiry for this product